As GLP-1 receptor agonists continue to be widely adopted for obesity and metabolic disease, it is essential to consider their broader implications for bone health and orthopedic surgery
Resolves quickly with proper fluid intake but requires ongoing vigilance Serious But Less Common Side Effects The MHRA highlights several serious but less common risks that patients should know about 1 : Gallbladder problems: Including gallstones Pancreatitis: Inflammation of the pancreas, which can require hospitalization Allergic reactions: Can include swelling, rash, and trouble breathing Low blood sugar: Can happen even in non-diabetic patients using GLP-1s for weight loss Hair loss: Some patients report temporary thinning of hair Warnings About Misuse Healthcare professionals are concerned about people using GLP-1 medications inappropriately just for cosmetic weight loss
GLP-1RAs also promote endothelial barrier integrity via activating protein kinase A (PKA)- and Ras-related C3 botulinum toxin substrate 1 (Rac1) [106]
In terms of safety and tolerability, the adverse events were primarily mild to moderate gastrointestinal reactions, with no reports of severe hypoglycemia or death
OVERALL SCORE Fair Based on our comprehensive hands-on evaluation Tested firsthand by me Signed up with Noom and purchased GLP-1s firsthand
The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)
